Characterization and biocompatibility of organogels based on L-alanine for parenteral drug delivery implants

被引:142
作者
Motulsky, A
Lafleur, M
Couffin-Hoarau, AC
Hoarau, D
Boury, F
Benoit, JP
Leroux, JC
机构
[1] Univ Montreal, Fac Pharm, Canada Res Chair Drug Delivery, Montreal, PQ H3C 3J7, Canada
[2] Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada
[3] Ethypharm Inc, Laval, PQ H7V 4A6, Canada
[4] INSERM, Ecole Prat Hautes Etud, Immeuble IBT, U 646, F-49100 Angers, France
基金
加拿大健康研究院;
关键词
in situ-forming implant; biocompatibility; controlled drug release; organogel;
D O I
10.1016/j.biomaterials.2005.04.004
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The development of simple and efficient drug delivery systems for the sustained release of peptides/proteins and low molecular weight hydrophilic molecules is an ongoing challenge. The purpose of this work was to prepare and characterize novel biodegradable in situ-forming implants obtained via the self-assembly Of L-alanine derivatives in pharmaceutical oils. Six different amphiphilic organogelators based on L-alanine were synthesized. These derivatives could successfully gel various vegetable and synthetic oils approved for parenteral administration. Gelation was thermoreversible, and phase transition temperatures depended on gelator structure, concentration and solvent. Hydrogen bonds and van der Waals interactions were shown to be the main forces implicated in network formation. Selected formulations were then injected subcutaneously in rats for preliminary assessment of biocompatibility. Histopathological analysis of the surrounding tissues revealed mild, chronic inflammation and an overall good biocompatibility profile of the implants over the 8 wk evaluation period. This study demonstrates that in situ-forming organogels represent a potentially promising platform for sustained drug delivery. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6242 / 6253
页数:12
相关论文
共 36 条
[1]   n-alkanes gel n-alkanes (and many other organic liquids) [J].
Abdallah, DJ ;
Weiss, RG .
LANGMUIR, 2000, 16 (02) :352-355
[2]   Biological responses to materials [J].
Anderson, JM .
ANNUAL REVIEW OF MATERIALS RESEARCH, 2001, 31 :81-110
[3]   Biodegradation and biocompatibility of PLA and PLGA microspheres [J].
Anderson, JM ;
Shive, MS .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 28 (01) :5-24
[4]  
ANDERSON JM, 1994, EUR J PHARM BIOPHARM, V40, P1
[5]   First report of phase selective gelation of oil from oil/water mixtures. Possible implications toward containing oil spills [J].
Bhattacharya, S ;
Krishnan-Ghosh, Y .
CHEMICAL COMMUNICATIONS, 2001, (02) :185-186
[6]   In situ-forming pharmaceutical organogels based on the self-assembly of L-alanine derivatives [J].
Couffin-Hoarau, AC ;
Motulsky, A ;
Delmas, P ;
Leroux, JC .
PHARMACEUTICAL RESEARCH, 2004, 21 (03) :454-457
[7]  
COUFFINHOARAU AC, 2002, Patent No. 60405720
[8]   TRANSLATING SAFETY, EFFICACY AND COMPLIANCE INTO ECONOMIC VALUE FOR CONTROLLED-RELEASE DOSAGE FORMS [J].
CRAMER, MP ;
SAKS, SR .
PHARMACOECONOMICS, 1994, 5 (06) :482-504
[9]   CONTROLLED-RELEASE OF CONTRACEPTIVE STEROIDS FROM BIODEGRADABLE AND INJECTABLE GEL FORMULATIONS - IN-VIVO EVALUATION [J].
GAO, ZH ;
CROWLEY, WR ;
SHUKLA, AJ ;
JOHNSON, JR ;
REGER, JF .
PHARMACEUTICAL RESEARCH, 1995, 12 (06) :864-868
[10]   Low molecular-mass gelators with diyne functional groups and their unpolymerized and polymerized gel assemblies [J].
George, M ;
Weiss, RG .
CHEMISTRY OF MATERIALS, 2003, 15 (15) :2879-2888